insights_auto
Why is OCUL down 3.22%?
Dive Deeperchevron_right
OCUL:NASDAQ
Ocular Therapeutix Inc
$6.01
arrow_downward
-3.22%(-0.20) 1D
$6.38
arrow_upward
+6.16% (+0.37)todayPre-market
Closed: Nov 16, 4:00:01 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OCUL...
Open
$6.16
High
$6.25
Low
$5.94
Mkt. cap
1.32B
Avg. vol.
2.95M
Volume
152.00
52-wk high
$16.44
52-wk low
$5.94
EPS
-$1.46
Beta
1.22
Shares outstanding
220.02M
No. of employees
325
Open
$6.16
High
$6.25
Low
$5.94
Mkt. cap
1.32B
Avg. vol.
2.95M
Volume
152.00
52-wk high
$16.44
52-wk low
$5.94
EPS
-$1.46
Beta
1.22
Shares outstanding
220.02M
No. of employees
325
News stories
From web sources and news partners
qz.com
·
38 minutes ago
5 Nasdaq-linked stock indexes and how each differs from the S&P 500
The Motley Fool
·
1 hour ago
Will Your S&P 500 Index Fund Be Forced to Buy Anthropic? Here’s What the Rules Say.
Trefis
·
4 hours ago
31 S&P 500 Stocks Just Made New 52-Week Highs
Traders Union
·
13 hours ago
Michael A. Gayed: S&P 500 fell 19.35% and high yield dropped 5.9% in Q4 2018 selloff
About Ocular Therapeutix Inc
CEOPravin Dugel
Employees325
Founded2006
HeadquartersBedford, Massachusetts, United States
SectorHealth Care
IndustryPharmaceutical industry
Websiteocutx.com